close icon-linkedin icon-twitter icon-facebook icon-mail icon-google-plus icon-search icon-phone icon-instagram
What are you looking for?
Valerie Betting

Valerie Betting

Trainee patent attorney
Motivated by my deep-rooted curiosity, I acquired know-how in the field of molecular biology, epigenetics and immunology. I am beyond excited to put my knowledge into practice as trainee patent attorney at NLO in the biotechnology sector. With a positive and goal-oriented mindset, I will give 110% to fortify the ideas of clients.


  • Antibody
  • Biotechnology
  • Oligonucleotide
  • Gene therapy

Patents are more than a legal document. They make it worthwhile to embrace creativity, and to act outside the box. I am looking forward to supporting clients through the entire intellectual property (IP) process, and to ensure that all pieces of the puzzle fall into place.

I have always been intrigued by the development of single cells into living beings, with specialised tissues and organs. To explore the molecular mechanisms that underlie such complex processes, I pursued a PhD focusing on epigenetic gene regulation. Interdisciplinary projects in my academic career allowed me to engage with inspiring, novel technologies, and develop strong communication skills. I believe this will enable me to obtain an in-depth understanding of clients’ needs.


  • PhD in Molecular Biology, Radboud Institute for Molecular Life Sciences
  • MSc in Molecular Mechanisms of Disease, Radboud University Nijmegen
  • BSc in Biology, Radboud University Nijmegen


  • Qu J, Betting V, Van Iterson R, Kwaschik FM, Van Rij RP. Chromatin profiling identifies transcriptional readthrough as a conserved mechanism for piRNA cluster biogenesis in mosquitoes. Cell Reports. 2023 Mar 28;42(3):112257.
  • Betting V, Joosten J, Halbach R, Thaler M, Miesen P, Van Rij RP. A piRNA-lncRNA regulatory network initiates responder and trailer piRNA formation during mosquito embryonic development. RNA. 2021 Oct 27(10):1155-1172.
  • Betting V, Van Rij RP. Countering Counter-Defense to Antiviral RNAi. Trends Microbiol. 2020 Aug 28(8):600-602.